BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34884696)

  • 1. Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network.
    Briede I; Balodis D; Gardovskis J; Strumfa I
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
    Cao H; Xu E; Liu H; Wan L; Lai M
    Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies.
    Visioli A; Giani F; Trivieri N; Pracella R; Miccinilli E; Cariglia MG; Palumbo O; Arleo A; Dezi F; Copetti M; Cajola L; Restelli S; Papa V; Sciuto A; Latiano TP; Carella M; Amadori D; Gallerani G; Ricci R; Alfieri S; Pesole G; Vescovi AL; Binda E
    EBioMedicine; 2019 Jun; 44():346-360. PubMed ID: 31056474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
    Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
    Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
    Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pre-existing population of ZEB2
    Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.
    Liu X; Fu Q; Du Y; Yang Y; Cho WC
    Curr Cancer Drug Targets; 2016; 16(9):738-754. PubMed ID: 26577538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise Review: Aggressive Colorectal Cancer: Role of Epithelial Cell Adhesion Molecule in Cancer Stem Cells and Epithelial-to-Mesenchymal Transition.
    Boesch M; Spizzo G; Seeber A
    Stem Cells Transl Med; 2018 Jun; 7(6):495-501. PubMed ID: 29667344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.
    Sarkar D; Shields B; Davies ML; Müller J; Wakeman JA
    Int J Cancer; 2012 Jan; 130(2):328-37. PubMed ID: 21365650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.
    Yao C; Su L; Shan J; Zhu C; Liu L; Liu C; Xu Y; Yang Z; Bian X; Shao J; Li J; Lai M; Shen J; Qian C
    Stem Cells; 2016 Apr; 34(4):820-31. PubMed ID: 26840943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
    Chang S; Sun G; Zhang D; Li Q; Qian H
    Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progression in metastasis of colorectal carcinoma].
    Zhao L; Ding YQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):486-93. PubMed ID: 25187466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Notch pathway in colorectal cancer.
    Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G
    Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.
    Findlay VJ; Wang C; Watson DK; Camp ER
    Cancer Gene Ther; 2014 May; 21(5):181-7. PubMed ID: 24787239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
    Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.